Old Web
English
Sign In
Acemap
>
Paper
>
Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer.
Primary Tumor Sidedness and Benefit from FOLFOXIRI plus Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer.
2018
Chiara Cremolini
Carlotta Antoniotti
S. Lonardi
Francesca Bergamo
Enrico Cortesi
Gianluca Tomasello
Roberto Moretto
Monica Ronzoni
P. Racca
F Loupakis
A. Zaniboni
G Tonini
Angela Buonadonna
Federica Marmorino
Giacomo Allegrini
Cristina Granetto
Gianluca Masi
Zagonel
Elisa Sensi
Gabriella Fontanini
L Boni
A Falcone
Keywords:
General surgery
FOLFOXIRI
Internal medicine
Primary tumor
Bevacizumab
Colorectal cancer
Medicine
Oncology
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]